去年，Cytek Biosciences Inc表现最佳的业务板块Biotechnology, pharmaceutical, distributor and CRO实现营收116.73M美元。United States的营收贡献最高，去年达到95.25M美元。最近一个季度，截至2026-06-30，Cytek Biosciences Inc表现最佳的业务板块Biotechnology, pharmaceutical, distributor and CRO实现营收29.02M美元。United States的营收贡献最高，达到28.22M美元。

业务

营业收入

占比

年报

年报

单季报

Biotechnology, pharmaceutical, distributor and CRO

Academia and government

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Biotechnology, pharmaceutical, distributor and CRO

116.73M(57.93%)

119.54M(59.64%)

110.87M(57.44%)

90.33M(55.07%)

68.53M(53.56%)

47.16M(50.80%)

26.31M(45.45%)

Academia and government

84.76M(42.07%)

80.91M(40.36%)

82.14M(42.56%)

73.71M(44.93%)

59.41M(46.44%)

45.67M(49.20%)

31.58M(54.55%)

地区

营业收入

占比

年报

年报

单季报

United States

EMEA

APAC

Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

95.25M(47.27%)

92.61M(46.20%)

102.08M(52.89%)

94.59M(57.67%)

72.72M(56.84%)

55.48M(59.76%)

38.15M(65.90%)

EMEA

55.88M(27.73%)

62.34M(31.10%)

53.18M(27.55%)

43.96M(26.80%)

36.97M(28.89%)

25.91M(27.91%)

11.48M(19.83%)

APAC

41.08M(20.39%)

35.77M(17.84%)

31.60M(16.37%)

22.52M(13.73%)

16.08M(12.57%)

10.74M(11.57%)

8.07M(13.94%)

Other

9.28M(4.61%)

9.73M(4.86%)

6.15M(3.19%)

2.96M(1.81%)

2.18M(1.70%)

710.00K(0.76%)

189.00K(0.33%)